A/H5 Inactivated Monovalent Influenza Vaccines(Biomedical Advanced Research And Development Authority)

N/A

Report date: 2026/03/27 20:01:50

Base Information

Drug NameA/H5 Inactivated Monovalent Influenza Vaccines(Biomedical Advanced Research And Development Authority)

Drug Alias NameA/H5 Inactivated Monovalent Influenza Vaccines at Different Antigen Dose Levels Adjuvanted With AS03® or MF59®SP0335SP-0335

ClassificationVaccines > Vaccine type > Univalent vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesBiomedical Advanced Research And Development Authority

China Registration ClassN/A

Develop Information

Active CompaniesBiomedical Advanced Research And Development Authority

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A